Navigation Links
OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Date:3/8/2013

FORT LAUDERDALE, Fla., March 8, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and its subsidiary, Orbus International B.V., (collectively, "OrbusNeich") today announced that they have commenced a patent infringement lawsuit in Ireland against Boston Scientific Corporation (NYSE: BSX) and two of its Irish subsidiaries (collectively, "Boston Scientific").

The lawsuit alleges that Boston Scientific are infringing two European patents covering certain novel stent designs.  The two patents, held by OrbusNeich, are designated EP 2 311 412 and EP 1 341 482.  OrbusNeich allege that the patents are infringed by a number of Boston Scientific's coronary stent systems, including the "PROMUS Element™", "PROMUS Element Plus™", "OMEGA™", "TAXUS™", "SYNERGY™", and "Promus PREMIER™" lines of stents.

OrbusNeich are seeking damages for the infringement and an injunction prohibiting Boston Scientific from manufacturing, offering for sale, marketing or stocking products that infringe the patents in Ireland.

Al Novak , Chairman and Chief Executive Officer of OrbusNeich, said, "The lawsuit in Ireland is a continuation of our efforts to protect and enforce our intellectual property rights. We intend to vigorously pursue these efforts to prevent unlawful competitive practices and protect our unique technologies throughout the world."

On February 20, 2013, OrbusNeich commenced patent infringement actions in Germany and the Netherlands against Boston Scientific and its distribution affiliates in those countries.  

On February 11, 2013, OrbusNeich received a favorable ruling from the European Patent Office (EPO) in connection with EP 1 341 482, one of the two patents asserted against Boston Scientific in these lawsuits. The EPO upheld the validity of claim 1 of the '482 patent, as amended, over an opposition filed by Boston Scientific and Terumo Kabushiki Kaisha.  The EPO found that claim 1 of the '482 patent met all requirements of the European Patent Convention, and that the stents covered by the claim were novel and inventive over the prior art.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous™ Stent, as well as other stents and balloons marketed under the names of Azule™, R stent™, Scoreflex™, Sapphire™, Sapphire II™ and Sapphire NC™. Development stage products include the COMBO Dual Therapy Stent™, the world's first dual therapy stent. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich supplies medical devices to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

Follow OrbusNeich on Twitter at www.twitter.com/OrbusNeich, and learn more about the company and its innovative technology on OrbusNeich's YouTube Channel: http://www.youtube.com/user/OrbusNeichMedia.


'/>"/>
SOURCE OrbusNeich
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Early Coronary Artery Healing Advantage of OrbusNeichs Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
2. OrbusNeich Announces Favorable Ruling From the European Patent Office
3. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
4. Essential Medical Dismisses Patent Case against Masimo and Cercacor
5. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
6. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
7. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
8. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
9. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
10. Broad Patent Protection Granted for iBio Immunomodulator
11. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has ... Industry 2016-2020" report to their offering. ... The global fluoropolymer market in the ... period 2016-2020. Global Fluoropolymer Market in the Healthcare ... with inputs from industry experts. The report covers the market landscape ...
(Date:1/17/2017)... 2017  In a letter to President-elect Donald ... outlines AARP,s priorities for Americans age 50 and ... to affordable health care coverage, and lowering the cost ... writes to President-elect Trump that "Our nearly 38 million ... you to protect their Medicare and Social Security benefits, ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  In a preview ... th Annual Congress, Astute Medical, Inc., developer of the ... of the test, which identifies hospital patients at risk of ... will take place this month at the Hawaii ... from January 21 through January 25. AKI is ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... ... partnership with Sigfox in the U.S.A. to offer Internet of Things ... new offerings on large-scale environmental sensor deployments such as monitoring solutions used to ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... companies and ranked among the top US security companies for consecutive years, today ... This announcement brings a year-long independent board nomination process to a close and ...
(Date:1/16/2017)... ... January 17, 2017 , ... To provide comfort and ... in the fast-casual category, announces a hearty and wholesome Winter Menu. Starting today, ... Turkey Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show ... Vegas, Booth #2809. The SHOT Show is the shooting, hunting and outdoor trade ...
Breaking Medicine News(10 mins):